Drugs made in america acquisition corp. rightsDMAAR.US Overview

US StockIndustrials

(No presentation for DMAAR)

Overview AI Analysis AI Earnings Summary Financials Financial Forecast Stock SentimentalTradingView Chart

DMAAR Overall Performance

DMAAR AI Analysis & Strategy

DMAAR Recent Performance

-10.76%

Drugs made in america acquisition corp. rights

-0.26%

Avg of Sector

-1.14%

S&P500

DMAAR PowerScanner

DMAAR Key Information

DMAAR Valuation Metrics

DMAAR Earnings Table

DMAAR Profile

Drugs Made In America Acquisition Corp. operates as a blank check company. The Company aims to acquire one and more businesses and assets, via a merger, capital stock exchange, asset acquisition, stock purchase, and reorganization.